Climate Change Challenges: Haemonetics’ Battle for Operational Efficiency and Market Share - TipRanks
Climate Change Challenges: Haemonetics’ Battle for Operational Efficiency and Market Share - TipRanks.com
Haemonetics ( HAE) has disclosed a new risk, in the Environmental / Social category.
Haemonetics faces heightened business risks due to climate change and the associated regulatory measures. The unpredictability of long-term climate effects threatens their operational efficiency and supply chain, particularly in the sourcing of raw materials and essential natural resources like water. Moreover, stringent climate-related legislation could impose greater compliance costs and disrupt product manufacturing and distribution. Failing to adapt to evolving customer preferences related to climate change could also lead to a loss of market share, adversely impacting Haemonetics’ financial stability and operational results.
Overall, Wall Street has a Strong Buy consensus rating on HAE stock based on 3 Buys and 1 Hold.
To learn more about Haemonetics’ risk factors, click here.
Related Knowledge Center: Climate economics
Climate change is now a driver of the world’s economy. The impact is profound:
- Catastrophic weather events — hurricanes, floods, droughts, high temperatures — are more frequent and more extreme. The cost can be measured in both the initial damage caused and the longer-term impact on the economy.
- Vulnerable communities are increasing climate-related investments, hardening infrastructure and taking other protective measures.
- Investment in carbon capture and storage technologies is increasingly rapidly.
- Governments are making investments and crafting regulations to reduce emissions of carbon dioxide and other greenhouse gases.
On top of all of this is the cost of uncertainty. As the Fourth National Climate Assessment, released in 2018 by the U.S. Global Change Research Program, says, “The assumption that current and future climate conditions will resemble the recent past is no longer valid.”